Dr. David Spigel on the Utility of Molecular Marker Results in the Adjuvant Setting for Early Stage Non-Small Cell Lung Cancer

Medicina, #adjuvant, #alk, #cancer, #cancergrace, #cannon, #center, #david, #egfr, #grace, #gracecast, #molecular, #mutation, #oncology, #postoperative, #rearrangement, #sarah, #spigel, #targeted, #therapy, #treatment